VoicePort, LLC announces a strategic integration agreement

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
VoicePort, LLC announces a strategic integration agreement with Scientific Technologies Corporation (STC) to bolster pharmacy-based immunization rates

ROCHESTER, N.Y., Nov. 3, 2015 (GLOBE NEWSWIRE) -- VoicePort, LLC announced today that they have entered into an agreement with Scientific Technologies Corporation (STC) to leverage its expertise in data integration and patient notification technologies to provide decision support and State Immunization Registry reporting to Pharmacy providers. VoicePort's platform, PharmaPhonetics®, provides a host of cloud-based services to today's Pharmacists including advanced data analytics, inbound/outbound interactive voice response, patient education, Medication Synchronization and performance measurement. This new partnership will expose to the pharmacist, specific immunization gaps based on Advisory Council on Immunization Practices (ACIP) recommendations and State Immunization Registry data. "Our vision is focused on providing the retail pharmacist with relevant, real-time information with the goal of active participation in today's collaborative care models", said Jeff Maltese, Vice President of Pharmacy Strategy. "With adult immunization rates still at low levels, the frequency of patient touchpoints and regulatory authorization represents a substantial opportunity for pharmacists to further impact patient care". The VoicePort PharmaPhonetics® Prescription Services Suite offers a seamless and differentiated approach to reaching multiple patients to address and support improved patient health and adherence in an automated and efficient manner. "Medication Adherence is an industry imperative that requires multiple strategies and tactics to address the various patient and disease states", said VoicePort President and CEO Chris Mann. "With the introduction of this integration, we've added an important tool to our adherence platform that will provide pharmacists with timely clinical decision support and compliance reporting". Mann further commented, "Our expertise in integrating with Pharmacy Management Systems and STC's industry leading immunization intelligence capabilities allows our pharmacy customers to efficiently identify patient vaccine eligibility right at the point of care ". "Our platform offers a high degree of flexibility and configurability designed to optimize our customer's specific technology, workflow and financial requirements as opposed to a one-size-fits-all approach" said Alphonse Sasso, Vice President of Business Development. Sasso further commented "Customers can decide which tools to employ at their discretion whether it's the seamless use of data-driven automated outbound notifications or direct patient engagement tools like MTM eligibility or immunization recommendations". About VoicePort Headquartered in Rochester, New York and founded in 2002, VoicePort develops and markets configurable communication solutions in the media, healthcare and pharmaceutical verticals. The company's solutions are helping clients efficiently communicate with customers and patients through the use of self or assisted-service enabled using Advanced Speech Recognition (ASR) technology and handle over 28 million patient conversations annually at more than 1,200 customer sites in North America. VoicePort maintains strategic relationships with partners such as with Aumtech, Inc., OneStream Networks, The Pharmacy Quality Alliance, STC and Polyglot, Inc. leveraging its expertise in automated self-service applications, analytics and pharmacy operations expertise to deliver a full suite of personalized multi-channel patient communication and adherence applications called PharmaPhonetics®. To find out more about our products and services, please visit www.voiceport.net About STC A leading public health informatics company in the U.S., STC creates technology solutions to address critical public health issues and to improve public health through the applied use of population health data. Founded in 1988, STC was one of the first companies to advocate for the value of immunization registries and public health data to augment clinical practice. Since then, STC has become the trusted authority on the applied use of information technology to collect immunization data and assist in solving complex challenges. STC's unique mix of public health advisors and information system software developers combine their talents to design innovative software solutions used in both the public and private sectors, by state public health departments as well as by the nation's leading pharmacies and physicians. With over 300 million vaccine encounters now retained in the immunization registries of STC and its state public health partners, STC plays a key role in protecting children and adults from diseases and helping to create healthier populations. For additional information about STC, please visit www.stchome.com .

Alphonse J. Sasso Vice President, Business Development 500 Lee Road Rochester, NY 14606 Phone: 585-248-9289 www.voiceport.net

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Odessa Water Overbilling Lawsuit Surges Ahead

Updated Category News Views 181

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

Continue Reading
AI Deception Challenges the Confidence of Fraud Defenses

Updated Category News Views 120

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Continue Reading
Choosing the Right Pressure-Treated Lumber for Projects

Updated Category News Views 115

Diving into the World of Pressure-Treated Lumber John Michael Nixa, the go-to expert from West Side Lumber, has dropped some real nuggets in the world of pressure-treated lumber. This isn't some clickbait headline; it's about making sure your deck or fence doesn't fall apart after the first thunderstorm. Understanding the Lumber Treatment Now, before you run off to the...

Continue Reading
Noël Jolié's Cream Earns Spot on Oprah's List

Updated Category News Views 98

The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...

Continue Reading
D-Wave's 9.5% Drop: Fraud Lawsuit Raises Investor Ire

Updated Category News Views 59

Shockwaves from D-Wave's Earnings Call August wasn't exactly a banner month for D-Wave Quantum, Inc. as their stock went down like a lead balloon following a lackluster earnings report. If you've ever had any skin in the game, you'd know a 9.5% drop isn't just peanuts—it's the equivalent of watching your prized racehorse stumble at the first hurdle. The financials spoke...

Continue Reading
Bybit Expands ByPick Game with Broader Market Reach

Updated Category News Views 124

Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...

Continue Reading
NVIDIA Faces Legal Turbulence: CEO's Exit Sparks Chaos

Updated Category News Views 98

Jensen Huang's Sudden Exit: A Barrage of Headlines In what feels like a blow delivered by a sledgehammer, NVIDIA is rocked by the abrupt resignation of its iconic co-founder and CEO, Jensen Huang. This isn't some quiet departure into the night. Nope, it's more like a cannonball being fired into the investor lounge, leaving a wreckage for all to navigate through. Huang's...

Continue Reading
Balancing Rigor and Interests in Education: Insights

Updated Category News Views 135

Education: A Balancing Act of Academics and Interests So here's the deal, folks. Education isn't just about hitting the textbooks and acing exams. It's a wild dance—balancing rigorous academics and the extracurricular hustle. Brent Reckman, the brains behind The Academy of Charter Schools in Westminster, Colorado, knows this orchestra well. In a feature with...

Continue Reading
Optikos Secures CMMC Level 2, Eyeing Defense Market

Updated Category News Views 92

Optikos Levels Up with CMMC Certification In a world where cybersecurity threats are lurking around every corner, Optikos has just joined the rarefied ranks of the top 1% of U.S. defense suppliers by grabbing the CMMC Level 2 certification. Let me tell you, this isn't just some shiny badge for show; it's a gateway to big defense contracts. Crunching the Numbers Of the...

Continue Reading
HNTB Partners with Kansas City Chiefs for New Stadium

Updated Category News Views 94

A New Chapter for the Kansas City Chiefs Are we witnessing the dawn of a new era for the Kansas City Chiefs? Officially naming HNTB as the architect for their upcoming stadium signals a strategic pivot, aimed at not just snagging eyeballs, but embedding Kansas City deeper into the sports architecture hall of fame. Unveiled during the Power Brokers Sports-Anchored...

Continue Reading

Top 5 Most Recently Viewed Articles

IMF Delegates Argentina Negotiations Amid Rising Tensions

Updated Category News Views 196

Understanding the Recent Developments in IMF Talks with Argentina The International Monetary Fund (IMF) is currently navigating a complicated landscape in its negotiations with Argentina, showcasing the ever-evolving nature of international finance and politics. Recently, Rodrigo Valdes, the IMF director for the Western Hemisphere, has officially assigned all negotiation...

Continue Reading
IO Biotech Showcases Innovative Cancer Treatments Through Vaccines

Updated Category News Views 194

IO Biotech Unveils Breakthrough Pre-Clinical Data for Cancer Vaccines IO Biotech, a clinical-stage biopharmaceutical company listed on the Nasdaq under the ticker IOBT, is at the forefront of developing immune-modulatory, off-the-shelf therapeutic cancer vaccines. Recently, the company revealed exciting data highlighting its two promising candidates: IO112 and IO170, both...

Continue Reading
Market Performance of Marijuana Stocks This October

Updated Category News Views 69

October Marijuana Stock Performance Overview The marijuana stock market has shown a diverse range of movements this October. Investors and enthusiasts remain eager to analyze these trends as companies navigate the ever-changing landscape of the cannabis industry. This article provides insights into the key movers within this sector, identifying both the top performers and...

Continue Reading
EQS Group Unveils 'Q': AI-Driven Compliance Revolution

Updated Category News Views 216

Compliance in the Fast Lane The compliance world just got a hefty upgrade with EQS Group's latest rollout: 'Q by EQS,' an AI-powered intelligence layer that's here to shake up the way compliance tasks are handled. It's integrated right into the heart of the EQS Compliance Cockpit, giving teams an edge by automating those pesky, time-sucking routines and guiding them...

Continue Reading
Olema Oncology Showcases Innovations at J.P. Morgan Healthcare Expo

Updated Category News Views 306

Olema Oncology to Present at Major Healthcare Event Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a dynamic clinical-stage biopharmaceutical company focused on developing targeted therapies for breast cancer and related conditions, is all set to present its innovative findings at the renowned J.P. Morgan Healthcare Conference. This key...

Continue Reading